Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep458 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Glucose scan behaviour in people with type 1 diabetes using flash glucose monitoring in a real-world setting

Hochfellner Daniel , Ziko Haris , Elsayed Hesham , Cigler Monika , Knoll Lisa , Pöttler Tina , Aberer Felix , Mader Julia

Introduction: Flash glucose monitoring (FGM) enables people with diabetes to regularly track their glucose levels without performing capillary finger-stick measurements (SMBG). Clinical studies have shown improvement in glycemic control, reduction of hypoglycemia, improvement in comfort and quality of life in people with type 1 diabetes (T1D) using this technology. In contrast to continuous glucose monitoring, FGM requires the performance of a scan to obtain the current glucos...

ea0070aep503 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Impact of isoflavone intervention on microbiota, predicted metagenome and metabolic profile in polycystic ovary syndrome

Haudum Christoph , Lindheim Lisa , Ascani Angelo , Trummer Christian , Münzker Julia , Horvath Angela , Obermayer-Pietsch Barbara

Objective: Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide and is associated with disorders of glucose metabolism. Hormone and metabolic signalling may be influenced by phytoestrogens, such as isoflavones. Their endocrine effects may modify symptom penetrance in PCOS.We investigated, whether women with PCOS and healthy controls differ in their capacity to metabolize dietary isoflavones and whether this capacity...

ea0070aep535 | Endocrine-related Cancer | ECE2020

Endocrine related immune adverse events associated with programmed death ligand-1 (PD-L1) therapy in hematologic malignancies: A retrospective analysis

Lo Preiato Valentina , Buganè Anna , Casadei Beatrice , Argnani Lisa , Luigi Zinzani Pier , Pagotto Uberto , Pelusi Carla

Background: PD-L1 represents a novel class of drugs for treatment of a broad spectrum of malignancies including onco-hematologic diseases. This treatment is associated with several immuno-related adverse events (irAEs). Thyroid diseases and diabetes are among the most common PD-L1 endocrine-irAEs reported in solid cancers.Aims: To describe the frequency, the onset and the characteristics of PD-L1 endocrine-irAEs in patients with hematologic malignancies....

ea0070aep999 | Thyroid | ECE2020

Pembrolizumab inducing thyroid diseases: Are there differences between patients treated for lung carcinomas and those for lymphomas?

Lo Preiato Valentina , Buganè Anna , Casadei Beatrice , Salvagni Stefania , Argnani Lisa , Ardizzoni Andrea , Luigi Zinzani Pier , Pagotto Uberto

Background: In the last years, Pembrolizumab has been used to treat solid and lymphatic neoplasms, showing improved patients’ survival. Due to its mechanism of action, Pembrolizumab may be responsible of several immune-related adverse events (irAEs). The most frequent endocrine-irAEs reported are thyroid diseases.Aims: The aim of this study was to evaluate differences in thyroid disease incidence and presentation between patients treated for lung c...

ea0031p176 | Nursing practice | SFEBES2013

Development of adult endocrine specialist nurse competencies

Shepherd Lisa , Davies Kate , Gibson Christine , Middleton Morag , Munday Jean , Shalet Shashana , Yeoh Phillip , Cragg Julie , Kieffer Veronica

The Society for Endocrinology Nurse Committee provides national, international and local guidance, support and networking for nurses working in Endocrinology. Following review and revalidation of the endocrine nurse certificate, the Nurse Committee looked to explicate adult endocrine nurse competencies. The need for core competencies to standardise role expectations was a concern voiced from nurses and committee members. Up to the introduction of paediatric endocrine nurse com...

ea0014p571 | (1) | ECE2007

Riluzole treatment does not affect growth hormone (GH) secretion in amyotrophic lateral sclerosis

Morselli Lisa Linda , Bongioanni Paolo , Genovesi Maura , Licitra Rosaria , Rossi Bruno , Murri Luigi , Gasperi Maurizio , Martino Enio

Amyotrophic lateral sclerosis (ALS), the most common motor neurone disorder in human adults, presents is characterized by selective and progressive degeneration of upper and lower motor neurones in central nervous system. GH secretion, evaluated by GHRH+arginine test, has been recently reported to be impaired in about 70% of untreated ALS patients. The currently available drug for ALS treatment is riluzole, a compound acting through inhibition of glutamate relase, post-synapti...

ea0056gp234 | Thyroid Cancer - Diagnostics & Treatments | ECE2018

Title Evaluation of the CCK-2-receptor agonist 177Lu-PP-F11N for peptide receptor radionuclide therapy (PRRT) of medullary thyroid carcinoma - First results of a phase 0 ‘Lumed’ Study

Rottenburger Christof , Nicolas Guillaume , McDougall Lisa , Kaul Felix , Cachovan Michael , Schibli Roger , Geistlich Susanne , Behe Martin , Wild Damian , Christ Emanuel

Objectives: There is still an unmet need for an effective systemic therapy for advanced medullary thyroid carcinoma (MTC). Targeting the cholecystokinine-2 (CCK-2) receptor with radiolabelled gastrin analogues is a potential approach for radionuclide therapy, as MTC expresses CCK-2 receptors at a high incidence and density. Unfortunately, kidney and bone marrow toxicity precluded therapeutic applications of CCK-2 receptor specific compounds until now. The aim of this prospecti...

ea0075a21 | Adrenal gland | EYES2021

Impact of COVID-19 on patients with primary adrenal insufficiency: A cross-sectional study

Knowles Gregory , Warmington Emily , Shepherd Lisa , Hazlehurst Jonathan , De Bray Anne , Gleeson Helena , Arlt Wiebke , Prete Alessandro

Background: Patients with primary adrenal insufficiency (PAI) carry an increased risk of infections which can precipitate adrenal crises. They are thought to be more likely to contract COVID-19 and develop severe disease; however, little is known about the true impact of COVID-19 on these patients.Objectives: To assess the response of a large single-centre cohort of PAI patients to COVID-19, focusing on morbidity and health promotion attitudes.<p cla...

ea0094p183 | Adrenal and Cardiovascular | SFEBES2023

The management of adrenal incidentalomas referred to the adrenal radiology meeting at heartlands hospital in 2021

Matthews Alexandra , Ul-Hassan Naeem , Shepherd Lisa , Joseph Sonia , Hazlehurst Jonathan , Miller Ben , Rahim Asad , Juszczak Agata

Background: An adrenal incidentaloma (AI) is an adrenal lesion found on imaging performed for an indication other than adrenal disease. The current European Society of Endocrinology guidelines recommend that all AIs are discussed in a dedicated adrenal multidisciplinary meeting.Method: We evaluated the outcomes of AI cases referred to the Adrenal Radiology Meeting (ARM) at Heartlands Hospital between January 2021 and Dec...

ea0094p351 | Metabolism, Obesity and Diabetes | SFEBES2023

Time-restricted eating in polycystic ovarian syndrome: a randomised crossover feasibility study of real-world clinical advice

Floyd Ruairi , Gibney James , Owens Lisa , Phelan Niamh , Rakovac Ana , Le Roux Carel , Duggan Sinead , Ann Behan Lucy

Objective: Time-restricted eating (TRE) represents a novel intervention that may improve insulinaemia and reduce weight, but is untested in polycystic ovarian syndrome (PCOS). In a randomised interventional study (NCT05126199), we investigated the feasibility of TRE in PCOS. Secondary objectives included effects on insulin and metabolic indices.Methods: Participants were randomised to 12-week TRE (18h fast/6h eating wind...